ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2340

Human Osteoclasts Are Mobilized in Erosive Arthritis of Epstein-Barr Virus-Infected Humanized NOD/Shi-Scid/IL-2Rγnull Mice

Yosuke Nagasawa1, Natsumi Ikumi2, Takamasa Nozaki1, Hirotake Inomata1, Kenichi Imadome3, Noboru Kitamura1, Mitsuhiro Iwata1, Shigeyoshi Fujiwara4 and Masami Takei1, 1Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 2Division of Heamatology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 3Department of Infectious Diseases, National Research Institute for Child Health and Development, Tokyo, Japan, 4Department of Iinfectious Diseases, National Research Institute for Child Health and Development, Tokyo, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: animal models and viruses, osteoclasts, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose

Various studies of the relationship between Epstein-Barr virus (EBV) and rheumatoid arthritis (RA) have not produced convincing evidence. Many human viruses do not infect mice; thus, it is difficult to conduct biomedical research. At this congress, we previously reported that EBV infection induces erosive arthritis that resembles RA in humanized NOD/Shi-scid/IL-2Rγnull (NOG) mice. However, the mechanisms underlying arthritis in this mouse model are unknown.

In this mouse model, osteoclast-like cells are observed during bone erosion. To determine whether the human or mouse immune system activates bone erosion, we analyzed the origin of osteoclasts in this mouse model.

Methods

The NOG mouse is a highly immunodeficient mouse strain. Seven-week-old female NOG mice were intravenously injected with human CD34+ stem cells from cord blood (1.0 × 105 cells/mouse). Characterization of human hematoimmune system reconstitution (we termed it humanization) was then performed. Human CD4+, CD8+, and CD45+ cells in peripheral blood of these humanized mice were quantified every week using flow cytometery. The engraftment rate of human cells and characteristics of lymphocytes were determined. After 3 months of humanization, these mice were intravenously infected with EBV (1.0 × 101 TD50/mouse). EBV was purified from EBV-producing cells (AKATA or B95-8). After 8-10 weeks of EBV infection, these mice were sacrificed. The joint tissue samples were stained with hematoxylin-eosin, stained for tartrate-resistant acid phosphatase (TRAP) with an immunoenzyme method, and immunostained for human cathepsin K (specific to humans and dogs). To let osteoclasts differentiate with progenitor cells, bone marrow cells from EBV-infected humanized NOG mice were cultured with human receptor activator of nuclear factor κB ligand (RANKL) and human macrophage colony-stimulating factor (M-CSF) in slide chambers. These stimulated multinucleated cells were subjected to TRAP staining and immunostaining for human cathepsin K and human mitochondria.

Results

After humanization, >40% of peripheral-blood lymphocytes in these mice were human CD45+ cells. When the number of human CD8+ T-cells increased and surpassed the number of human CD4+ T-cells in peripheral blood, erosive arthritis was observed histologically at a high rate (approximately 90%). Multinucleated cells present in the bone erosion zone were positive for human cathepsin K and TRAP staining. Multinucleated giant cells resembling osteoclasts were observed among cultured bone marrow cells stimulated with human RANKL and M-CSF. Human cathepsin K, mitochondrial, and TRAP staining were all positive in these multinucleated cells.

Conclusion

In this mouse model, we achieved a high engraftment rate. The relationship between the degree of arthritis and the ratio of CD4+ to CD8+ T-cell numbers in peripheral blood was evident. Osteoclasts present in the bone erosion zone originated from human cells. In addition, observed that multinucleated giant cells among bone marrow cells cultured with human RANKL and M-CSF were osteoclasts and originated from human cells.


Disclosure:

Y. Nagasawa,
None;

N. Ikumi,
None;

T. Nozaki,
None;

H. Inomata,
None;

K. Imadome,
None;

N. Kitamura,
None;

M. Iwata,
None;

S. Fujiwara,
None;

M. Takei,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/human-osteoclasts-are-mobilized-in-erosive-arthritis-of-epstein-barr-virus-infected-humanized-nodshi-scidil-2r%ce%b3null-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology